International Congress of Dermatology 2025: Galderma’s Scientific Presentations
Galderma will present data from across its Therapeutic Dermatology portfolio at the XIV International Congress of Dermatology (ICD), taking place in Rome, Italy, on June 18-21, 2025, including updates on its investigations in acne, non-melanoma skin cancer, and prurigo nodularis.
First author | Abstract title | Presentation type |
S. Ständer | Nemolizumab long-term efficacy and safety up to 100 weeks in the OLYMPIA open-label extension study in patients with prurigo nodularis: An interim analysis | Late-breaking abstract
Presented Saturday, June 21, 2025, at 08:30 – 08:35 AM CET Orange room |
R. Szeimies | Personalizing Actinic Keratosis Treatment for Immunocompromised Patients (IM-PAKT): Patient scenarios | E-poster #1673 |
R. Szeimies | Artificial daylight photodynamic therapy with methyl aminolevulinate (ArtLight): A real-world study | E-poster #1675 |
A. Moore | Quantifying pigmentation: A colorimetric analysis assessing the impact of trifarotene on acne-induced hyperpigmentation (AIH) | E-poster #1680 |
M. Schaller | Recommendations for long-term rosacea management from The Rosacea — Expert Advice on Combined and Holistic approaches (REACH) group’s Global Scientific Committee | E-poster #1677 |
Galderma will also host a symposium at ICD, exploring the latest advances in addressing itch and lesion control in both prurigo nodularis and atopic dermatitis. Further details can be found here and below.
Speakers | Symposium title | Details |
Prof. Sarina Elmariah Dr. Brian Kim Prof. Martin Metz Dr. Andrew Pink | Ditching the Itch: Latest Advances in Itch Relief and Long-Term Lesion Control for Atopic Dermatitis and Prurigo Nodularis | Friday, June 20 12:30 – 1:30 PM CET Green Room |
